Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
45
HSIC Quote, Financials, Valuation and Earnings
Last price:
$69.39
Seasonality move
:
-0.43%
Day range:
$68.71 - $71.19
52-week range:
$60.56 - $82.49
Dividend yield:
0%
P/E ratio:
21.66x
P/S ratio:
0.69x
P/B ratio:
2.55x
Volume:
2.1M
Avg. volume:
1.7M
1-year change:
2.56%
Market cap:
$8.4B
Revenue:
$12.7B
EPS (TTM):
$3.20
Analysts' Opinion
-
Consensus RatingHenry Schein has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 9 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $76.42, Henry Schein has an estimated upside of 10.25% from its current price of $69.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $55.00 representing 20.66% downside risk from its current price of $69.32.
Fair Value
-
According to the consensus of 12 analysts, Henry Schein has 10.25% upside to fair value with a price target of $76.42 per share.
HSIC vs. S&P 500
-
Over the past 5 trading days, Henry Schein has underperformed the S&P 500 by -6.59% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Henry Schein does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Henry Schein revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Henry Schein reported revenues of $3.2B.
Earnings Growth
-
Henry Schein has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Henry Schein reported earnings per share of $0.88.
Enterprise value:
12.6B
EV / Invested capital:
--
Price / LTM sales:
0.69x
EV / EBIT:
18.91x
EV / Revenue:
1.00x
PEG ratio (5yr expected):
2.80x
EV / Free cash flow:
24.82x
Price / Operating cash flow:
17.27x
Enterprise value / EBITDA:
13.26x
Gross Profit (TTM):
$4B
Return On Assets:
3.94%
Net Income Margin (TTM):
3.21%
Return On Equity:
8.28%
Return On Invested Capital:
5.42%
Operating Margin:
6.31%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $12.5B | $12.5B | $12.7B | $3.2B | $3.2B | |
| Gross Profit | $3.8B | $3.9B | $4B | $1B | $1B | |
| Operating Income | $839M | $650M | $771M | $160M | $200M | |
| EBITDA | $889M | $867M | $951M | $230M | $253M | |
| Diluted EPS | $3.52 | $2.97 | $3.20 | $0.72 | $0.88 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.6B | $3.8B | $4B | $4.1B | $4B | |
| Total Assets | $7.8B | $8.4B | $8.6B | $10.1B | $10.5B | |
| Current Liabilities | $2.1B | $2.1B | $2.2B | $2.3B | $2.9B | |
| Total Liabilities | $3.3B | $3.6B | $3.9B | $5.1B | $5.8B | |
| Total Equity | $4.4B | $4.8B | $4.7B | $5B | $4.7B | |
| Total Debt | $685.1M | $866M | $1.3B | $2.4B | $2.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $536M | $670M | $688M | $197M | $37M | |
| Cash From Investing | -$288M | -$1.2B | -$457M | -$72M | -$99M | |
| Cash From Financing | -$232M | $529M | -$270M | -$151M | $89M | |
| Free Cash Flow | $387M | $473M | $508M | $147M | -$6M | |
HSIC
Sector
Market Cap
$8.4B
$34.4M
Price % of 52-Week High
84.03%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
4.34%
-1.01%
1-Year Price Total Return
2.56%
-37.36%
Beta (5-Year)
0.866
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$72.52
200-day SMA
Sell
Level
$71.51
Bollinger Bands (100)
Sell
Level
66.71 - 73.53
Chaikin Money Flow
Sell
Level
-4.7M
20-day SMA
Sell
Level
$72.69
Relative Strength Index (RSI14)
Sell
Level
35.45
ADX Line
Sell
Level
20.2
Williams %R
Buy
Level
-91.3475
50-day SMA
Sell
Level
$71.43
MACD (12, 26)
Buy
Level
19.46
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Sell
Level
-7.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.0615)
Sell
CA Score
(Annual)
Level (-0.4461)
Buy
Beneish M-Score
(Annual)
Level (-2.8767)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-0.5538)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Stock Forecast FAQ
In the current month, HSIC has received 2 Buy ratings 9 Hold ratings, and 1 Sell ratings. The HSIC average analyst price target in the past 3 months is $76.42.
-
Where Will Henry Schein Stock Be In 1 Year?
According to analysts, the consensus estimate is that Henry Schein share price will rise to $76.42 per share over the next 12 months.
-
What Do Analysts Say About Henry Schein?
Analysts are divided on their view about Henry Schein share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Henry Schein is a Sell and believe this share price will drop from its current level to $55.00.
-
What Is Henry Schein's Price Target?
The price target for Henry Schein over the next 1-year time period is forecast to be $76.42 according to 12 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is HSIC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Henry Schein is a Hold. 9 of 12 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HSIC?
You can purchase shares of Henry Schein via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Henry Schein shares.
-
What Is The Henry Schein Share Price Today?
Henry Schein was last trading at $69.39 per share. This represents the most recent stock quote for Henry Schein. Yesterday, Henry Schein closed at $69.32 per share.
-
How To Buy Henry Schein Stock Online?
In order to purchase Henry Schein stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.46% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.66% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 8.52% over the past day.
